The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

Two-day conference on cardiology ...

A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe ...

More than 24,000 people were waiting for a cardiology appointment as of September 2024, a 252% increase on the number waiting ...

Humanitarianism is about building the kind of world we want to live in. Change isn’t optional but a responsibility. So…let’s act with urgency, compassion and purpose. The heart of the movement is ...

Since the donation of a SPECT camera by the International Atomic Energy Agency (IAEA), a busy hospital in Brazil's city of Niteroi has doubled its ...

What Lies Ahead for Praluent? Projections indicate that the Praluent market will continue its upward trajectory in the coming years: .Market Value Forecast: Expected to reach $XX million by 2029.

The Australian patient underwent the procedure on November 22 at St Vincent’s Hospital in Sydney, in a six-hour operation.

Artrya Limited ( ($AU:AYA) ) has shared an update. Artrya Limited has announced the issuance of 25,000 ordinary shares following the exercise and ...

Since the donation of a SPECT camera by the International Atomic Energy Agency (IAEA), a busy hospital in Brazil’s city of Niteroi has doubled its capacity to perform heart scans, expanding access to ...